Literature DB >> 16924640

Circumstances of death in adult sickle cell disease patients.

Deepika S Darbari1, Paul Kple-Faget, John Kwagyan, Sohail Rana, Victor R Gordeuk, Oswaldo Castro.   

Abstract

The purpose of the study was to analyze clinical and/or autopsy findings at the time of death among adults with sickle cell disease (SCD) at Howard University in Washington, DC over a 25-year period. A single physician recorded circumstances of death among 141 adult SCD patients he treated and knew well from 1976 to 2001. These findings were determined by autopsy report and/or clinical assessment. In a subset of 31 patients, autopsy records were reviewed for reports of iron deposition in liver and heart and of organ pathology. One hundred and fourteen (80.9%) of the patients had SS phenotype and 66 (46.8%) were female. The mean +/- SD age at death was 36 +/- 11 years. Leading circumstances of death included pulmonary hypertension (PHT) (26.2%), sudden death (23.4%), renal failure (22.6%), infection (18.4%), thromboembolism (14.9%), cardiac diagnoses (12.0%), cirrhosis (11.3%), pneumonia or acute chest syndrome (9.9%), bleeding (7.8%), and iron overload (7.0%). When circumstances of deaths that occurred after 1991 (n = 69) were compared to those that occurred in 1991 or earlier (n = 72), PHT (36.2% vs. 16.6%; P < 0.01) was significantly more common in 1992 or later. Significant associations were found between PHT and thromboembolism and between cirrhosis and iron overload. In this proportional mortality study of adults with SCD, PHT was the leading finding at the time of death. Thromboembolism was associated with PHT, and iron overload was associated with cirrhosis. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2006        PMID: 16924640     DOI: 10.1002/ajh.20685

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  73 in total

1.  Vascular risk assessment in patients with sickle cell disease.

Authors:  Claudia R Morris
Journal:  Haematologica       Date:  2011-01       Impact factor: 9.941

2.  Reproductive health choices for young adults with sickle cell disease or trait: randomized controlled trial immediate posttest effects.

Authors:  Diana J Wilkie; Agatha M Gallo; Yingwei Yao; Robert E Molokie; Christine Stahl; Patricia E Hershberger; Zhongsheng Zhao; Marie L Suarez; Robert J Labotka; Bonnye Johnson; Rigo Angulo; Veronica Angulo; Jesus Carrasco; David Shuey; Stephanie Pelligra; Edward Wang; Dennie T Rogers; Alexis A Thompson
Journal:  Nurs Res       Date:  2013 Sep-Oct       Impact factor: 2.381

3.  A comparison of analgesic management for emergency department patients with sickle cell disease and renal colic.

Authors:  Matthew P Lazio; Heather H Costello; D Mark Courtney; Zoran Martinovich; Randall Myers; Amy Zosel; Paula Tanabe
Journal:  Clin J Pain       Date:  2010 Mar-Apr       Impact factor: 3.442

4.  Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease.

Authors:  Vandana Sachdev; Roberto F Machado; Yukitaka Shizukuda; Yesoda N Rao; Stanislav Sidenko; Inez Ernst; Marilyn St Peter; Wynona A Coles; Douglas R Rosing; William C Blackwelder; Oswaldo Castro; Gregory J Kato; Mark T Gladwin
Journal:  J Am Coll Cardiol       Date:  2007-01-16       Impact factor: 24.094

5.  A novel human gamma-globin gene vector for genetic correction of sickle cell anemia in a humanized sickle mouse model: critical determinants for successful correction.

Authors:  Ajay Perumbeti; Tomoyasu Higashimoto; Fabrizia Urbinati; Robert Franco; Herbert J Meiselman; David Witte; Punam Malik
Journal:  Blood       Date:  2009-05-27       Impact factor: 22.113

6.  Abnormal autonomic cardiac response to transient hypoxia in sickle cell anemia.

Authors:  S Sangkatumvong; T D Coates; M C K Khoo
Journal:  Physiol Meas       Date:  2008-05-07       Impact factor: 2.833

7.  Peripheral vasoconstriction and abnormal parasympathetic response to sighs and transient hypoxia in sickle cell disease.

Authors:  Suvimol Sangkatumvong; Michael C K Khoo; Roberta Kato; Jon A Detterich; Adam Bush; Thomas G Keens; Herbert J Meiselman; John C Wood; Thomas D Coates
Journal:  Am J Respir Crit Care Med       Date:  2011-08-15       Impact factor: 21.405

8.  Sickle cell disease is associated with iron mediated hypercoagulability.

Authors:  Nirmish Shah; Ian J Welsby; Martha A Fielder; Wayne K Jacobsen; Vance G Nielsen
Journal:  J Thromb Thrombolysis       Date:  2015-08       Impact factor: 2.300

9.  Emergency Department Sickle Cell Assessment of Needs and Strengths (ED-SCANS), a focus group and decision support tool development project.

Authors:  Paula Tanabe; Christopher Reddin; Victoria L Thornton; Knox H Todd; Ted Wun; John S Lyons
Journal:  Acad Emerg Med       Date:  2010-08       Impact factor: 3.451

Review 10.  Cardiovascular abnormalities in sickle cell disease.

Authors:  Mark T Gladwin; Vandana Sachdev
Journal:  J Am Coll Cardiol       Date:  2012-03-27       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.